Enrollment
critically ill
CRITICALLY ILL
The first participant was randomly assigned to a study group on February 26, 2021. Enrollment was discontinued in the critically ill group on June 22, 2022, by the trial leadership in coordination with the study sponsor given a marked slowing of the enrollment rate of critically ill patients. At that time, 479 participants were randomly assigned to receive a P2Y12 inhibitor, and 470 participants were randomly assigned to usual care (